Reports Of Delay In Licensing For Covaxin ''Factually Incorrect'': Centre

The Union government is consistently and pro-actively working to secure and enhance the availability of vaccines, the Health Ministry said.

The government on Thursday dismissed as "completely baseless and factually incorrect" reports in a section of media followed by some tweets alleging delay in licensing for Covaxin and delayed approval for technology transfer for manufacturing the vaccine in the country. The Union government is consistently and pro-actively working to secure and enhance the availability of vaccines, the Health Ministry said, adding that Government of India is pro-actively engaging with foreign vaccine manufacturers like Moderna, Pfizer to apply for emergency use authorisation in India so that these vaccines can be easily imported and made available in the country. Simultaneously, Government of India, along with other like-minded countries, is also stressing on IPR waiver for COVID-19 vaccines. These two interventions, taken in conjunction, will ensure easy availability of vaccines not only in India but globally too, the ministry said in its statement. "There have been reports in a section of the media followed by some uninformed tweets alleging delay in licensing for Covaxin and delayed approval for technology transfer for manufacturing Covaxin vaccine in the country.